|
80
|
301
|
8b56A |
Crystal structure of sars-cov-2 main protease (mpro) in complex with the inhibitor gd-9 |
|
102
|
320
|
8t8nA |
Venezuelan equine encephalitis virus (veev) nonstructural protein 2 (nsp2) cysteine protease inhibited with ca074 |
|
86
|
306
|
8tbeA |
Co-crystal structure of sars-cov-2 mpro with pomotrelvir |
|
155
|
469
|
8tbxA |
Crystal structure of human ddx1 helicase in complex with adp |
|
80
|
304
|
8frjA |
Structure of nsp14 n7-methyltransferase domain fused with telsam bound to sgc0946 |
|
82
|
305
|
7urbB |
Sars-cov2 main protease in complex with cdd-1733 |
|
79
|
299
|
8frkA |
Structure of nsp14 n7-methyltransferase domain fused with telsam bound to sgc8158 |
|
85
|
306
|
7ur9A |
Sars-cov2 main protease in complex with inhibitor cdd-1845 |
|
87
|
302
|
7us4A |
Sars-cov2 main protease in complex with cdd-1819 |
|
0
|
15
|
8cmgC |
Human leukocyte antigen class ii allotype dr1 presenting sars-cov-2 nsp14 peptide (orf1ab)6420-6434 |
|
175
|
733
|
8fkyNI |
Human nucleolar pre-60s ribosomal subunit (state f) |
|
80
|
301
|
8gfnA |
Room temperature x-ray structure of truncated sars-cov-2 main protease c145a mutant, residues 1-304, in complex with bbh1 |
|
86
|
302
|
8gfrA |
Room temperature x-ray structure of truncated sars-cov-2 main protease c145a mutant, residues 1-304, in complex with nbh2 |
|
82
|
302
|
8gfkA |
Room temperature x-ray structure of truncated sars-cov-2 main protease c145a mutant, residues 1-304 |
|
83
|
302
|
8gfoA |
Room temperature x-ray structure of truncated sars-cov-2 main protease c145a mutant, residues 1-304, in complex with gc373 |
|
82
|
302
|
8gfuA |
Room temperature x-ray structure of truncated sars-cov-2 main protease c145a mutant, residues 1-304, in complex with nirmatrelvir (nmv) |
|
179
|
733
|
8fkxNI |
Human nucleolar pre-60s ribosomal subunit (state e) |
|
146
|
680
|
8fkuNI |
Human nucleolar pre-60s ribosomal subunit (state c2) |
|
181
|
803
|
8fkvNI |
Human nucleolar pre-60s ribosomal subunit (state d1) |
|
140
|
451
|
8fkuSW |
Human nucleolar pre-60s ribosomal subunit (state c2) |
|
130
|
451
|
8fkrSW |
Human nucleolar pre-60s ribosomal subunit (state b1) |
|
141
|
451
|
8fktSW |
Human nucleolar pre-60s ribosomal subunit (state c1) |
|
146
|
680
|
8fktNI |
Human nucleolar pre-60s ribosomal subunit (state c1) |
|
131
|
451
|
8fkqSW |
Human nucleolar pre-60s ribosomal subunit (state a2) |
|
134
|
451
|
8fksSW |
Human nucleolar pre-60s ribosomal subunit (state b2) |
|
141
|
451
|
8fkvSW |
Human nucleolar pre-60s ribosomal subunit (state d1) |
|
129
|
451
|
8fkpSW |
Human nucleolar pre-60s ribosomal subunit (state a1) |
|
147
|
451
|
8fkxSW |
Human nucleolar pre-60s ribosomal subunit (state e) |
|
144
|
451
|
8fkySW |
Human nucleolar pre-60s ribosomal subunit (state f) |
|
75
|
305
|
8didA |
Virtual screening for novel sars-cov-2 main protease non-covalent and covalent inhibitors |
|
80
|
304
|
8diiA |
Virtual screening for novel sars-cov-2 main protease non-covalent and covalent inhibitors |
|
82
|
300
|
8digA |
Virtual screening for novel sars-cov-2 main protease non-covalent and covalent inhibitors |
|
84
|
305
|
8dieA |
Virtual screening for novel sars-cov-2 main protease non-covalent and covalent inhibitors |
|
77
|
300
|
8difA |
Virtual screening for novel sars-cov-2 main protease non-covalent and covalent inhibitors |
|
85
|
304
|
8dibA |
Virtual screening for novel sars-cov-2 main protease non-covalent and covalent inhibitors |
|
82
|
304
|
8dihA |
Virtual screening for novel sars-cov-2 main protease non-covalent and covalent inhibitors |
|
80
|
305
|
8dicA |
Virtual screening for novel sars-cov-2 main protease non-covalent and covalent inhibitors |
|
84
|
298
|
8huuA |
Crystal structure of hcov-nl63 main protease with s217622 |
|
91
|
294
|
8a23A |
Crystal structure of sars-cov-2 nsp10/nsp16 methyltransferase in complex with to383 |
|
82
|
348
|
8d34A |
Crystal structure of sars cov-2 nsp15 endroribonuclease h250a |
|
27
|
109
|
8a23B |
Crystal structure of sars-cov-2 nsp10/nsp16 methyltransferase in complex with to383 |
|
88
|
306
|
8skhA |
Co-structure of sars-cov-2 (covid-19 with covalent pyrazoline based inhibitors |
|
86
|
305
|
8sk4A |
Co-structure of sars-cov-2 (covid-19 with covalent pyrazoline based inhibitors) |
|
84
|
501
|
8cxgA |
Structures of zika virus in complex with antibodies targeting e dimer epitopes and basis for neutralization efficacy |
|
83
|
501
|
8cxiA |
Structures of zika virus in complex with antibodies targeting e dimer epitopes and basis for neutralization efficacy |
|
88
|
305
|
8d4pA |
Crystal structure of the sars-cov-2 (covid-19) main protease in complex with inhibitor jun10-90-3-c1 |
|
18
|
75
|
8cxgD |
Structures of zika virus in complex with antibodies targeting e dimer epitopes and basis for neutralization efficacy |
|
18
|
75
|
8cxiD |
Structures of zika virus in complex with antibodies targeting e dimer epitopes and basis for neutralization efficacy |
|
83
|
501
|
8cxhA |
Structures of zika virus in complex with antibodies targeting e dimer epitopes and basis for neutralization efficacy |
|
19
|
75
|
8cxhD |
Structures of zika virus in complex with antibodies targeting e dimer epitopes and basis for neutralization efficacy |
